ImmunityBio, Inc. (IBRX)
7.91
+0.19
(+2.46%)
USD |
NASDAQ |
Sep 11, 16:00
7.92
+0.01
(+0.13%)
After-Hours: 20:00
ImmunityBio Price : 7.91 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 7.80 | 8.345 | 7.80 | 7.91 | 12.47M |
| Sep 10, 2026 | 7.87 | 7.89 | 7.64 | 7.72 | 8.806M |
| Sep 09, 2026 | 8.22 | 8.36 | 7.875 | 8.06 | 9.489M |
| Sep 08, 2026 | 8.00 | 8.37 | 7.93 | 8.29 | 7.741M |
| Sep 04, 2026 | 8.08 | 8.24 | 8.01 | 8.08 | 4.330M |
| Sep 03, 2026 | 8.00 | 8.21 | 7.88 | 8.19 | 5.272M |
| Sep 02, 2026 | 7.945 | 8.28 | 7.755 | 7.95 | 7.228M |
| Sep 01, 2026 | 7.82 | 7.99 | 7.73 | 7.87 | 6.466M |
| Aug 31, 2026 | 7.88 | 8.020 | 7.84 | 7.95 | 6.882M |
| Aug 28, 2026 | 8.31 | 8.320 | 7.945 | 8.05 | 7.980M |
| Aug 27, 2026 | 8.24 | 8.76 | 8.18 | 8.40 | 12.31M |
| Aug 26, 2026 | 8.17 | 8.40 | 8.07 | 8.25 | 9.446M |
| Aug 25, 2026 | 7.69 | 8.23 | 7.68 | 8.19 | 11.55M |
| Aug 24, 2026 | 7.68 | 7.72 | 7.46 | 7.58 | 5.672M |
| Aug 21, 2026 | 7.85 | 7.95 | 7.60 | 7.79 | 7.620M |
| Aug 20, 2026 | 7.90 | 8.00 | 7.74 | 7.84 | 8.099M |
| Aug 19, 2026 | 8.08 | 8.27 | 7.94 | 8.13 | 13.06M |
| Aug 18, 2026 | 7.785 | 7.83 | 7.54 | 7.72 | 5.413M |
| Aug 17, 2026 | 7.55 | 7.95 | 7.44 | 7.92 | 6.816M |
| Aug 14, 2026 | 7.59 | 7.59 | 7.430 | 7.57 | 4.913M |
| Aug 13, 2026 | 7.80 | 7.955 | 7.59 | 7.65 | 6.007M |
| Aug 12, 2026 | 7.71 | 7.82 | 7.60 | 7.74 | 5.340M |
| Aug 11, 2026 | 7.54 | 7.66 | 7.48 | 7.60 | 5.033M |
| Aug 10, 2026 | 7.51 | 7.70 | 7.42 | 7.49 | 6.002M |
| Aug 07, 2026 | 7.40 | 7.65 | 7.25 | 7.64 | 9.391M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 143.97 |
| Sarepta Therapeutics, Inc. | 20.45 |
| Arrowhead Pharmaceuticals, Inc. | 82.85 |
| Oncolytics Biotech, Inc. | 0.7455 |
| Sangamo Therapeutics, Inc. | 0.1485 |
Price Related Metrics
| PS Ratio | 47.87 |
| PEG Ratio | -0.0845 |
| Earnings Yield | -12.25% |
| Market Cap | 8.331B |
| PEGY Ratio | -0.0845 |